Stay updated with breaking news from Nasdaq Gbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has earned an average rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1-year price target […]
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people...
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people...
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has been assigned an average recommendation of “Hold” from the six analysts that are currently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among […]
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 1,350,000 shares, a decline of 33.2% from the November 30th total of 2,020,000 shares. Based on an average daily volume of 799,800 shares, […]